RCM
Revelation Capital Management Portfolio holdings
AUM
$4.26M
This Quarter Return
-40.62%
1 Year Return
-80.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$7.07M
AUM Growth
+$7.07M
(-74%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-191.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$430K |
Top Sells
| 1 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$10.2M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$3.07M |
| 3 |
Neuropace
NPCE
|
$656K |
Sector Composition
| 1 | Healthcare | 93.92% |
| 2 | Industrials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
1
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $5.41M | 76.54% |
1,415,846
-804,105
| -36% | -$3.07M |
|
|
2
Neuropace
NPCE
$303M
| $1.23M | 17.38% |
248,127
-132,578
| -35% | -$656K |
|
|
ACCD
3
DELISTED
Accolade, Inc. Common Stock
ACCD
| $430K | 6.08% |
+58,050
| New | +$430K |
|
|
ME
4
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| – | – |
-2,667,736
| Closed | -$10.2M |
|